Yes the strength is the product. The motto 'pain relief and nothing else' is great and instantly portrays our advantage over competition.
The packaging is attractive.
They are going to produce different sizes. That will address any pricing concerns.
Their ARE many positives.
Atleast we have reached end game. Or half time if you include Tripeptofen. Soon we will have $2mil to spend on marketing. If we are still left wondering in a few months then the company has failed to capitalise.
- Forums
- ASX - By Stock
- CAI
- providing sample to every games participant
providing sample to every games participant, page-15
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAI (ASX) to my watchlist
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.67M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
CAI (ASX) Chart |
Day chart unavailable
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online